The company posted net income attributable to common stock holders of $4.03m, or $0.13 per diluted share, compared to $3.07m, or $0.10 per diluted share, for the same period in 2008.

For the full year ended December 31, 2009, the company posted a net income attributable to common stock holders of $19.4m, or $0.61 per diluted share, compared to $16.65m, or 0.52 per diluted share, for the year ago period. Revenue was $136.08m, an increase of 24.9 percent, compared to $108.99m for the year ago period.

For 2010, the company plans to open an additional 160 pharmacy stores and expand the product portfolio which it manufactures to gain market share. In addition, China Baicaotang plans to invest in advanced logistics and information management systems and maximize its utilization rate of Hefeng production capacity.

Hui Tian Tang, chairman and CEO of the company, said: “We closed 2009 with solid results, achieving double-digit growth in revenue and net income. Our unique, vertically integrated business model combines manufacturing capabilities with the largest regional wholesale network in Guangxi and an extensive retail network position.

“We continue to focus on expanding our dominant position in second and third tier cities in Guangxi Province in order to take advantage of China's $124.3 billion universal healthcare bill, which targets rural areas.”

Will the company continue at same pace in Q1 2010?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.